Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

New imaging approaches for precision diagnosis and disease staging of MS?

Oh J, Sicotte NL.

Mult Scler. 2020 Jan 22:1352458519871817. doi: 10.1177/1352458519871817. [Epub ahead of print]

PMID:
31965887
2.

Collaborative International Research in Clinical and Longitudinal Experience Study in NMOSD.

Cook LJ, Rose JW, Alvey JS, Jolley AM, Kuhn R, Marron B, Pederson M, Enriquez R, Yearley J, McKechnie S, Han MH, Tomczak AJ, Levy M, Mealy MA, Coleman J, Bennett JL, Johnson R, Barnes-Garcia M, Traboulsee AL, Carruthers RL, Lee LE, Schubert JJ, McMullen K, Kister I, Rimler Z, Reid A, Sicotte NL, Planchon SM, Cohen JA, Ivancic D, Sedlak JL, Sand IK, Repovic P, Amezcua L, Pruitt A, Amundson E, Chitnis T, Mullin DS, Klawiter EC, Russo AW, Riley CS, Onomichi KB, Levine L, Nelson KE, Nealon NM, Engel C, Kruse-Hoyer M, Marcille M, Tornes L, Rumpf A, Greer A, Kenneally Behne M, Rodriguez RR, Behne DW, Blackway DW, Coords B, Blaschke TF, Sheard J, Smith TJ, Behne JM, Yeaman MR; Guthy-Jackson Charitable Foundation International Clinical Consortium (GJCF–ICC).

Neurol Neuroimmunol Neuroinflamm. 2019 Jun 28;6(5):e583. doi: 10.1212/NXI.0000000000000583. eCollection 2019 Sep.

3.

Imaging outcome measures of neuroprotection and repair in MS: A consensus statement from NAIMS.

Oh J, Ontaneda D, Azevedo C, Klawiter EC, Absinta M, Arnold DL, Bakshi R, Calabresi PA, Crainiceanu C, Dewey B, Freeman L, Gauthier S, Henry R, Inglese M, Kolind S, Li DKB, Mainero C, Menon RS, Nair G, Narayanan S, Nelson F, Pelletier D, Rauscher A, Rooney W, Sati P, Schwartz D, Shinohara RT, Tagge I, Traboulsee A, Wang Y, Yoo Y, Yousry T, Zhang Y, Sicotte NL, Reich DS; North American Imaging in Multiple Sclerosis Cooperative.

Neurology. 2019 Mar 12;92(11):519-533. doi: 10.1212/WNL.0000000000007099. Epub 2019 Feb 20. Review. Erratum in: Neurology. 2019 Jul 2;93(1):46.

PMID:
30787160
4.

Incidence of multiple sclerosis misdiagnosis in referrals to two academic centers.

Kaisey M, Solomon AJ, Luu M, Giesser BS, Sicotte NL.

Mult Scler Relat Disord. 2019 May;30:51-56. doi: 10.1016/j.msard.2019.01.048. Epub 2019 Feb 2.

PMID:
30738280
5.

Multisite reliability and repeatability of an advanced brain MRI protocol.

Schwartz DL, Tagge I, Powers K, Ahn S, Bakshi R, Calabresi PA, Todd Constable R, Grinstead J, Henry RG, Nair G, Papinutto N, Pelletier D, Shinohara R, Oh J, Reich DS, Sicotte NL, Rooney WD; NAIMS Cooperative.

J Magn Reson Imaging. 2019 Sep;50(3):878-888. doi: 10.1002/jmri.26652. Epub 2019 Jan 16.

PMID:
30652391
6.

An Automated Statistical Technique for Counting Distinct Multiple Sclerosis Lesions.

Dworkin JD, Linn KA, Oguz I, Fleishman GM, Bakshi R, Nair G, Calabresi PA, Henry RG, Oh J, Papinutto N, Pelletier D, Rooney W, Stern W, Sicotte NL, Reich DS, Shinohara RT; North American Imaging in Multiple Sclerosis Cooperative.

AJNR Am J Neuroradiol. 2018 Apr;39(4):626-633. doi: 10.3174/ajnr.A5556. Epub 2018 Feb 22.

7.

The NAIMS cooperative pilot project: Design, implementation and future directions.

Oh J, Bakshi R, Calabresi PA, Crainiceanu C, Henry RG, Nair G, Papinutto N, Constable RT, Reich DS, Pelletier D, Rooney W, Schwartz D, Tagge I, Shinohara RT, Simon JH, Sicotte NL; NAIMS Cooperative Steering Committee.

Mult Scler. 2018 Nov;24(13):1770-1772. doi: 10.1177/1352458517739990. Epub 2017 Nov 6.

8.

Volumetric Analysis from a Harmonized Multisite Brain MRI Study of a Single Subject with Multiple Sclerosis.

Shinohara RT, Oh J, Nair G, Calabresi PA, Davatzikos C, Doshi J, Henry RG, Kim G, Linn KA, Papinutto N, Pelletier D, Pham DL, Reich DS, Rooney W, Roy S, Stern W, Tummala S, Yousuf F, Zhu A, Sicotte NL, Bakshi R; NAIMS Cooperative.

AJNR Am J Neuroradiol. 2017 Aug;38(8):1501-1509. doi: 10.3174/ajnr.A5254. Epub 2017 Jun 22.

9.

Gradient nonlinearity effects on upper cervical spinal cord area measurement from 3D T1 -weighted brain MRI acquisitions.

Papinutto N, Bakshi R, Bischof A, Calabresi PA, Caverzasi E, Constable RT, Datta E, Kirkish G, Nair G, Oh J, Pelletier D, Pham DL, Reich DS, Rooney W, Roy S, Schwartz D, Shinohara RT, Sicotte NL, Stern WA, Tagge I, Tauhid S, Tummala S, Henry RG; North American Imaging in Multiple Sclerosis Cooperative(NAIMS).

Magn Reson Med. 2018 Mar;79(3):1595-1601. doi: 10.1002/mrm.26776. Epub 2017 Jun 15.

10.

The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.

Sati P, Oh J, Constable RT, Evangelou N, Guttmann CR, Henry RG, Klawiter EC, Mainero C, Massacesi L, McFarland H, Nelson F, Ontaneda D, Rauscher A, Rooney WD, Samaraweera AP, Shinohara RT, Sobel RA, Solomon AJ, Treaba CA, Wuerfel J, Zivadinov R, Sicotte NL, Pelletier D, Reich DS; NAIMS Cooperative.

Nat Rev Neurol. 2016 Dec;12(12):714-722. doi: 10.1038/nrneurol.2016.166. Epub 2016 Nov 11. Review.

PMID:
27834394
11.

Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.

Voskuhl RR, Wang H, Wu TC, Sicotte NL, Nakamura K, Kurth F, Itoh N, Bardens J, Bernard JT, Corboy JR, Cross AH, Dhib-Jalbut S, Ford CC, Frohman EM, Giesser B, Jacobs D, Kasper LH, Lynch S, Parry G, Racke MK, Reder AT, Rose J, Wingerchuk DM, MacKenzie-Graham AJ, Arnold DL, Tseng CH, Elashoff R.

Lancet Neurol. 2016 Jan;15(1):35-46. doi: 10.1016/S1474-4422(15)00322-1. Epub 2015 Nov 29.

12.

Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.

Kern KC, Gold SM, Lee B, Montag M, Horsfall J, O'Connor MF, Sicotte NL.

Neuroimage Clin. 2014 Dec 27;8:440-7. doi: 10.1016/j.nicl.2014.12.015. eCollection 2015.

13.

Neuroprotective effects of testosterone treatment in men with multiple sclerosis.

Kurth F, Luders E, Sicotte NL, Gaser C, Giesser BS, Swerdloff RS, Montag MJ, Voskuhl RR, Mackenzie-Graham A.

Neuroimage Clin. 2014 Mar 6;4:454-60. doi: 10.1016/j.nicl.2014.03.001. eCollection 2014.

14.

Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling.

Gold SM, O'Connor MF, Gill R, Kern KC, Shi Y, Henry RG, Pelletier D, Mohr DC, Sicotte NL.

Hum Brain Mapp. 2014 Jan;35(1):30-7. doi: 10.1002/hbm.22154. Epub 2012 Jul 30.

15.

Fornix damage limits verbal memory functional compensation in multiple sclerosis.

Kern KC, Ekstrom AD, Suthana NA, Giesser BS, Montag M, Arshanapalli A, Bookheimer SY, Sicotte NL.

Neuroimage. 2012 Feb 1;59(3):2932-40. doi: 10.1016/j.neuroimage.2011.09.071. Epub 2011 Oct 6.

PMID:
22001266
16.

Magnetic resonance imaging in multiple sclerosis: the role of conventional imaging.

Sicotte NL.

Neurol Clin. 2011 May;29(2):343-56. doi: 10.1016/j.ncl.2011.01.005. Review.

PMID:
21439445
17.

Neuroimaging in multiple sclerosis: neurotherapeutic implications.

Sicotte NL.

Neurotherapeutics. 2011 Jan;8(1):54-62. doi: 10.1007/s13311-010-0008-y. Review.

18.

Corpus callosal diffusivity predicts motor impairment in relapsing-remitting multiple sclerosis: a TBSS and tractography study.

Kern KC, Sarcona J, Montag M, Giesser BS, Sicotte NL.

Neuroimage. 2011 Apr 1;55(3):1169-77. doi: 10.1016/j.neuroimage.2010.10.077. Epub 2010 Nov 5.

PMID:
21056674
19.

Smaller cornu ammonis 2-3/dentate gyrus volumes and elevated cortisol in multiple sclerosis patients with depressive symptoms.

Gold SM, Kern KC, O'Connor MF, Montag MJ, Kim A, Yoo YS, Giesser BS, Sicotte NL.

Biol Psychiatry. 2010 Sep 15;68(6):553-9. doi: 10.1016/j.biopsych.2010.04.025. Epub 2010 Jun 19.

20.

Optic disk and white matter abnormalities in a patient with a de novo 18p partial monosomy.

Abu-Amero KK, Hellani A, Salih MA, Alorainy IA, Zidan G, Kern KC, Sicotte NL, Bosley TM.

Ophthalmic Genet. 2010 Sep;31(3):147-54. doi: 10.3109/13816810.2010.492817.

PMID:
20565246
21.

Estrogen treatment decreases matrix metalloproteinase (MMP)-9 in autoimmune demyelinating disease through estrogen receptor alpha (ERalpha).

Gold SM, Sasidhar MV, Morales LB, Du S, Sicotte NL, Tiwari-Woodruff SK, Voskuhl RR.

Lab Invest. 2009 Oct;89(10):1076-83. doi: 10.1038/labinvest.2009.79. Epub 2009 Aug 10.

22.

Regional hippocampal atrophy in multiple sclerosis.

Sicotte NL, Kern KC, Giesser BS, Arshanapalli A, Schultz A, Montag M, Wang H, Bookheimer SY.

Brain. 2008 Apr;131(Pt 4):1134-41. doi: 10.1093/brain/awn030.

PMID:
18375977
23.

A longitudinal fMRI study of the paced auditory serial addition task.

Cardinal KS, Wilson SM, Giesser BS, Drain AE, Sicotte NL.

Mult Scler. 2008 May;14(4):465-71. doi: 10.1177/1352458507084263. Epub 2008 Jan 21.

PMID:
18208900
24.

Detection and segmentation of pathological structures by the extended graph-shifts algorithm.

Corso JJ, Yuille A, Sicotte NL, Toga A.

Med Image Comput Comput Assist Interv. 2007;10(Pt 1):985-93.

PMID:
18051154
25.

Testosterone treatment in multiple sclerosis: a pilot study.

Sicotte NL, Giesser BS, Tandon V, Klutch R, Steiner B, Drain AE, Shattuck DW, Hull L, Wang HJ, Elashoff RM, Swerdloff RS, Voskuhl RR.

Arch Neurol. 2007 May;64(5):683-8.

PMID:
17502467
26.

Diffusion tensor MRI shows abnormal brainstem crossing fibers associated with ROBO3 mutations.

Sicotte NL, Salamon G, Shattuck DW, Hageman N, Rüb U, Salamon N, Drain AE, Demer JL, Engle EC, Alger JR, Baloh RW, Deller T, Jen JC.

Neurology. 2006 Aug 8;67(3):519-21.

PMID:
16894121
27.

Normal variants of Microcephalin and ASPM do not account for brain size variability.

Woods RP, Freimer NB, De Young JA, Fears SC, Sicotte NL, Service SK, Valentino DJ, Toga AW, Mazziotta JC.

Hum Mol Genet. 2006 Jun 15;15(12):2025-9. Epub 2006 May 10.

PMID:
16687438
28.

Handedness in twins: a meta-analysis.

Sicotte NL, Woods RP, Mazziotta JC.

Laterality. 1999 Jul;4(3):265-86.

PMID:
15513117
29.

Mutations in a human ROBO gene disrupt hindbrain axon pathway crossing and morphogenesis.

Jen JC, Chan WM, Bosley TM, Wan J, Carr JR, Rüb U, Shattuck D, Salamon G, Kudo LC, Ou J, Lin DD, Salih MA, Kansu T, Al Dhalaan H, Al Zayed Z, MacDonald DB, Stigsby B, Plaitakis A, Dretakis EK, Gottlob I, Pieh C, Traboulsi EI, Wang Q, Wang L, Andrews C, Yamada K, Demer JL, Karim S, Alger JR, Geschwind DH, Deller T, Sicotte NL, Nelson SF, Baloh RW, Engle EC.

Science. 2004 Jun 4;304(5676):1509-13. Epub 2004 Apr 22.

30.

Dysregulation of IL-10 and IL-12p40 in secondary progressive multiple sclerosis.

Soldan SS, Alvarez Retuerto AI, Sicotte NL, Voskuhl RR.

J Neuroimmunol. 2004 Jan;146(1-2):209-15.

PMID:
14698865
31.

Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol.

Soldan SS, Alvarez Retuerto AI, Sicotte NL, Voskuhl RR.

J Immunol. 2003 Dec 1;171(11):6267-74.

32.

Comparison of multiple sclerosis lesions at 1.5 and 3.0 Tesla.

Sicotte NL, Voskuhl RR, Bouvier S, Klutch R, Cohen MS, Mazziotta JC.

Invest Radiol. 2003 Jul;38(7):423-7.

PMID:
12821856
33.

Treatment of multiple sclerosis with the pregnancy hormone estriol.

Sicotte NL, Liva SM, Klutch R, Pfeiffer P, Bouvier S, Odesa S, Wu TC, Voskuhl RR.

Ann Neurol. 2002 Oct;52(4):421-8.

PMID:
12325070
34.

Onset of multiple sclerosis associated with anti-TNF therapy.

Sicotte NL, Voskuhl RR.

Neurology. 2001 Nov 27;57(10):1885-8.

PMID:
11723281
35.

Optical imaging of bilingual cortical representations. Case report.

Pouratian N, Bookheimer SY, O'Farrell AM, Sicotte NL, Cannestra AF, Becker D, Toga AW.

J Neurosurg. 2000 Oct;93(4):676-81.

PMID:
11014547
36.
37.

Automated image registration: II. Intersubject validation of linear and nonlinear models.

Woods RP, Grafton ST, Watson JD, Sicotte NL, Mazziotta JC.

J Comput Assist Tomogr. 1998 Jan-Feb;22(1):153-65.

PMID:
9448780

Supplemental Content

Loading ...
Support Center